KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $10.4 billion.

  • Biogen's Total Non-Current Liabilities fell 157.34% to $10.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.4 billion, marking a year-over-year decrease of 157.34%. This contributed to the annual value of $10.4 billion for FY2025, which is 157.34% down from last year.
  • Biogen's Total Non-Current Liabilities amounted to $10.4 billion in Q4 2025, which was down 157.34% from $10.2 billion recorded in Q3 2025.
  • Biogen's Total Non-Current Liabilities' 5-year high stood at $13.0 billion during Q3 2023, with a 5-year trough of $9.9 billion in Q1 2023.
  • Its 5-year average for Total Non-Current Liabilities is $10.9 billion, with a median of $10.7 billion in 2022.
  • Examining YoY changes over the last 5 years, Biogen's Total Non-Current Liabilities showed a top increase of 1906.73% in 2023 and a maximum decrease of 1768.27% in 2023.
  • Biogen's Total Non-Current Liabilities (Quarter) stood at $11.6 billion in 2021, then fell by 11.86% to $10.2 billion in 2022, then rose by 10.2% to $11.3 billion in 2023, then dropped by 5.89% to $10.6 billion in 2024, then dropped by 1.57% to $10.4 billion in 2025.
  • Its Total Non-Current Liabilities was $10.4 billion in Q4 2025, compared to $10.2 billion in Q3 2025 and $9.9 billion in Q2 2025.